Today we present 19 new placebo and nocebo research papers, comments and abstracts identified during January 2020. As usual, they are based on new PUBMED publication using the search terms „placebo“ and „nocebo“ and are hand-selected from more than 758 new publications during the preceding month. Previously published monthly updates can be found in our archive. Todays selection as well as all previously identified papers will also go into our placebo research library that currently contains more than 4,500 relevant papers. If you would like to get access to the full database, please register for our newsletter and provide us with your email address and affiliation.
Amanzio, M., & Palermo, S. (2020).
Nocebo effects and psychotropic drug action – an update. Expert Rev Clin Pharmacol, 1-3. doi:10.1080/17512433.2020.1722100
https://www.ncbi.nlm.nih.gov/pubmed/31995411
Anderson, D. E., German, R. E., Harrison, M. E., Bourassa, K. N., & Taylor, C. E. (2020).
Real and Perceived Effects of Caffeine on Sprint Cycling in Experienced Cyclists. J Strength Cond Res. doi:10.1519/JSC.0000000000003537
https://www.ncbi.nlm.nih.gov/pubmed/31996613
Bashyam, A. M., Cuellar-Barboza, A., Ghamrawi, R. I., & Feldman, S. R. (2020).
Placebo tailoring improves patient satisfaction of treatment plans in atopic dermatitis. J Am Acad Dermatol. doi:10.1016/j.jaad.2020.01.044
https://www.ncbi.nlm.nih.gov/pubmed/32004644
Bates, M. E., Mun, E. Y., Buckman, J. F., Vaschillo, E., Vaschillo, B., Lehrer, P., Udo, T., & Lesnewich, L. M. (2020).
Getting to the heart of low sensitivity to alcohol: Context moderates low cardiovascular response to alcohol in persons with a family history of alcohol use disorder. Alcohol Clin Exp Res. doi:10.1111/acer.14293
https://www.ncbi.nlm.nih.gov/pubmed/31984514
Bhat, V., Sengupta, S. M., Grizenko, N., & Joober, R. (2020).
Therapeutic response in children with ADHD: role of observers and settings. World J Pediatr. doi:10.1007/s12519-019-00332-5
https://www.ncbi.nlm.nih.gov/pubmed/31965445
Druart, L., Graham Longsworth, S., Rolland, C., Dolgopoloff, M., Terrisse, H., Bosson, J. L., & Pinsault, N. (2020).
Can an Open-Label Placebo Be as Effective as a Deceptive Placebo? Methodological Considerations of a Study Protocol. Medicines, 7(1). doi:10.3390/medicines7010003
https://www.ncbi.nlm.nih.gov/pubmed/31906435
Faig-Marti, J., & Martinez-Catassus, A. (2020).
Measuring the placebo effect in carpal tunnel syndrome. J Orthop Traumatol, 21(1), 1. doi:10.1186/s10195-019-0540-4
https://www.ncbi.nlm.nih.gov/pubmed/31993783
Fleischmann, R., Jairath, V., Mysler, E., Nicholls, D., & Declerck, P. (2020).
Nonmedical Switching From Originators to Biosimilars: Does the Nocebo Effect Explain Treatment Failures and Adverse Events in Rheumatology and Gastroenterology? Rheumatol Ther. doi:10.1007/s40744-019-00190-7
https://www.ncbi.nlm.nih.gov/pubmed/31950442
Gniss, S., Kappesser, J., & Hermann, C. (2020).
Placebo effect in children: the role of expectation and learning. doi:10.1097/j.pain.0000000000001811
https://www.ncbi.nlm.nih.gov/pubmed/31977929
House, S. A., Gadomski, A. M., & Ralston, S. L. (2020).
Evaluating the Placebo Status of Nebulized Normal Saline in Patients With Acute Viral Bronchiolitis: A Systematic Review and Meta-analysis. JAMA Pediatr. doi:10.1001/jamapediatrics.2019.5195
https://www.ncbi.nlm.nih.gov/pubmed/31905239
Kokoti, L., Drellia, K., Papadopoulos, D., & Mitsikostas, D. D. (2020).
Placebo and nocebo phenomena in anti- CGRP monoclonal antibody trials for migraine prevention: a meta-analysis. J Neurol. doi:10.1007/s00415-019-09673-7
https://www.ncbi.nlm.nih.gov/pubmed/31919565
Krauss, L., Ott, C., Opwis, K., Meyer, A., & Gaab, J. (2019).
Impact of Contextualizing Information on Aesthetic Experience and Psychophysiological Responses to Art in a Museum: A Naturalistic Randomized Controlled Trial. Psychology of Aesthetics, Creativity, and the Arts.
https://doi.org/10.1037/aca0000280
Krol, F. J., Hagin, M., Vieta, E., Harazi, R., Lotan, A., Strous, R. D., Lerer, B., & Popovic, D. (2020).
Placebo-To be or not to be? Are there really alternatives to placebo-controlled trials? Eur Neuropsychopharmacol. doi:10.1016/j.euroneuro.2019.12.117
https://www.ncbi.nlm.nih.gov/pubmed/31959380
Manai, M., van Middendorp, H., Veldhuijzen, D. S., van der Pol, J. A., Huizinga, T. W. J., & Evers, A. W. M. (2020).
Pharmacological conditioning in the treatment of recent-onset rheumatoid arthritis: a randomized controlled trial study protocol. Trials, 21(1), 15. doi:10.1186/s13063-019-3777-6
https://www.ncbi.nlm.nih.gov/pubmed/31907004
Neri, F., Mencarelli, L., Menardi, A., Giovannelli, F., Rossi, S., Sprugnoli, G., Rossi, A., Pascual-Leone, A., Salvador, R., Ruffini, G., & Santarnecchi, E. (2020).
A novel tDCS sham approach based on model-driven controlled shunting. Brain Stimul, 13(2), 507-516. doi:10.1016/j.brs.2019.11.004
https://www.ncbi.nlm.nih.gov/pubmed/31926812
Petersen, T. H., & Puthusserypady, S. (2019).
Assessing tDCS Placebo Effects on EEG and Cognitive Tasks. Conf Proc IEEE Eng Med Biol Soc, 2019, 4509-4512. doi:10.1109/EMBC.2019.8857549
https://www.ncbi.nlm.nih.gov/pubmed/31946867
Rotem, A., Ben-Sheetrit, J., Newcorn, J., Danieli, Y., Peskin, M., Golubchik, P., Ben-Hayun, R., Weizman, A., & Manor, I. (2020).
The Placebo Response in Adult ADHD as Objectively Assessed by the TOVA Continuous Performance Test. J Atten Disord, 1087054719897819. doi:10.1177/1087054719897819
https://www.ncbi.nlm.nih.gov/pubmed/31965885
Schienle, A., Gremsl, A., & Schwab, D. (2020).
Placebos can change affective contexts: An event-related potential study. Biol Psychol, 150, 107843. doi:10.1016/j.biopsycho.2020.107843
https://www.ncbi.nlm.nih.gov/pubmed/31945399
Tasso, A. F., Perez, N. A., Moore, M., Griffo, R., & Nash, M. R. (2020).
Hypnotic Responsiveness and Nonhypnotic Suggestibility: Disparate, Similar, or the Same? Int J Clin Exp Hypn, 68(1), 38-67. doi:10.1080/00207144.2020.1685330
https://www.ncbi.nlm.nih.gov/pubmed/31914365